RPL34P23

Across TCGA pan-cancer cohorts, RPL34P23 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RPL34P23 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL34P23 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL34P23 expression acts as an unfavorable survival marker, although some lineages such as OV and BLCA show a favorable association.

KIRC, KICH, and OV are the cancer types where RPL34P23 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.276	0.560	<.001	96	view →
KICH	DFS	Tertile	All	0.043	0.971	<.001	63	view →
OV	DFS	Median	III,IV	0.434	0.327	.001	44	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
BLCA	DFS	Tertile	All	0.832	0.550	.025	30	view →
PAAD	OS	Tertile	All	0.213	0.470	.030	18	view →
SKCM	OS	Tertile	All	0.750	0.876	.015	18	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	18	view →
COAD	DFS	Tertile	All	0.901	0.652	.007	9	view →
SARC	OS	Tertile	All	0.602	0.837	.038	6	view →
ESCA	OS	Median	III,IV	0.539	0.311	.024	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RPL34P23–KIRC (DFS)

Open the KIRC breakdown →